Olivia Ghaw, MD
img_Olivia Ghaw
ASSOCIATE PROFESSOR | Medicine, Rheumatology
Are you a patient?
Specialties
Internal Medicine, Rheumatology
: Safety and Efficacy of Tocilizumab versus Placebo in Combination with Disease Modifying Anti-Rheumatic Drugs in Patients with Moderate to Severe Active Rheumatoid Arthritis

·         Preceptors: Peter D. Gorevic, M.D., Chief, Rheumatology Division

August 2008- Present

Phase 2 Study of Uricase-PEG 20 in Humans with Hyperuricemia and Gout
 

Evaluation of Tuberculosis screening strategies in patients with Rheumatoid Arthritis using cutaneous antigen testing and whole blood Quantiferon®-TB assay

·         Preceptors: Clifton O. Bingham III, M.D., and Jeffrey Greenberg, M.D.

·         Site: Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases.

2003-2004

BA, Wellesley College

MD, New York University School of Medicine

Residency, Internal Medicine, Mount Sinai Hospital

Fellowship, Rheumatology, Mount Sinai Hospital

Certifications

American Board of Internal Medicine

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Ghaw has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.